相关实验视频
Updated: Jul 5, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.7K
区域酸抗凝药:一个不止两个故事的故事
Thomas Demuynck1, Muriel Grooteman2, Piet Ter Wee2
1Department of Nephrology, University Hospitals Leuven, Leuven, Belgium.
Seminars in nephrology
|January 11, 2024
概括
区域酸盐抗凝剂 (RCA) 通过结合,有效地抑制透析期间的血液凝固. 这种方法为患有出血风险的患者提供了对肝素的安全替代品.
科学领域:
- 生物化学 生物化学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
背景情况:
- 对于血液凝固至关重要.
- 酸可化,抑制凝血级联.
- 酸盐被用作输血和透析中的抗凝剂 (区域酸盐抗凝剂 - RCA).
研究的目的:
- 讨论使用酸盐作为透析中的抗凝剂.
- 为了比较在RCA期间补充的不同方法.
- 评估RCA作为高出血风险患者肝素的替代品.
主要方法:
- 区域酸盐抗凝药 (RCA) 涉及将酸盐注入体外电路,以结合电离.
- 补充的两种主要策略是:经典的RCA (输入管道) 和高透析剂.
- 对电离和电解质的监测至关重要.
主要成果:
- 在体外循环中,RCA有效地降低了血液凝固的倾向.
- 经典的RCA与无效输液是高效的低凝血.
- 高透析剂简化了RCA的输送,稳定了全身水平.
结论:
- 区域酸盐抗凝剂是透析的安全有效的抗凝剂.
- RCA是肝素的可行的替代品,特别是在高出血风险的患者中.
- 需要仔细管理水平,以获得最佳的RCA疗效和安全.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
422
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
422
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
518
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
518

